PEB Shorts Hold at 17% as Options Flip Sharply Bullish

Pebblebrook Hotel Trust reports Q3 results on October 30 with short interest near a one-month high and options traders repositioning dramatically in the other direction.

Short sellers have added to positions steadily through October, with the short interest figure climbing to 17.4% of the free float, roughly 19.75 million shares. That is up 13.7% from a month ago and 7.2% from a week ago, keeping PEB among the most shorted names in the hotel REIT space. Official FINRA data from mid-October corroborate the picture, placing the position at just under 20 million shares with 9 days to cover. Yet the borrow market remains relaxed rather than strained. Availability sits at 356%, meaning there are more than three and a half shares still available to borrow for every one already on loan. Cost to borrow is 0.43%, barely moved over the past week. Neither metric points to covering pressure.

Options positioning tells a very different story from the short book. The put/call ratio has collapsed to 0.186, the lowest reading in the past year and more than a standard deviation below its 20-day average of 1.37. For most of October the ratio sat well above 1.5, indicating heavy demand for downside protection. That defensive stance has reversed sharply this week, as call buying has dominated. The stock has moved with it, gaining 5.1% over the past week against a peer median closer to 2%, while peers such as Park Hotels and Xenia Hotels posted a mixed week.

The analyst community arrived at the print with targets lifting but ratings cautious. Evercore ISI and Wells Fargo both raised targets in the past week, to $21 and $20 respectively, while keeping neutral-equivalent ratings. Morgan Stanley, maintaining Underweight, raised its target to $15, still well below the current price of $21.72. The mean target across the consensus sits at $19.63, meaning the stock is already trading above the average street target after its 16% gain over the past month. The bull case rests on NAV recovery in San Francisco, better-than-expected EBITDA from legacy properties, and market share gains management has flagged on recent calls. Bears focus on concentrated exposure to high-risk urban markets where international inbound demand remains weak, stubborn margin pressure from staffing costs, and the risk that post-renovation EBITDA uplift takes longer to arrive than the share price now implies.

One ownership note worth carrying in: T. Rowe Price has been a notable buyer, lifting its 13G stake to 7.6% from 5.4% in its August amendment, and the institutional data show T. Rowe added more than 2.2 million shares in the most recent quarter. On the other side, Alyeska Investment Group cut its holding to 2.2% from 5.5%, a sizeable reduction. ORTEX's retail-attention signal is also running at a z-score of 4.2, its highest reading in the tracked window, suggesting the stock has attracted a surge of individual-investor interest alongside the institutional repositioning.

The print will test whether the operational improvements management has described can translate into numbers that justify a share price now above most analyst targets, with a crowded short position yet to materially retreat.